Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

ANK C/X Impl B9.5/D4.5/L9.5: medical device reports filed with FDA

4,960 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

4,960
device reports naming the brand
0% of all MAUDE reports · about 701 a year
798
reports, 12 months to August 2026
782 in the 12 months before
0.1%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

4,960 medical device reports received by FDA name the brand "ANK C/X Impl B9.5/D4.5/L9.5" (implant endosseous root-form); the manufacturer given most often on reports is Dentsply Implants Manufacturing; received from June 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

798 reports arrived in the 12 months to August 2026, close to the 782 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.9%) and malfunction (0.1%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (44.4%), loss of osseointegration (28.6%) and osseointegration problem (25.2%). The patient problems coded most often are failure of implant, inflammation and osteolysis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

060119Sep 2021: 27Oct 2021: 57Nov 2021: 70Dec 2021: 742022Jan 2022: 84Feb 2022: 47Mar 2022: 73Apr 2022: 68May 2022: 100Jun 2022: 75Jul 2022: 50Aug 2022: 63Sep 2022: 57Oct 2022: 64Nov 2022: 67Dec 2022: 572023Jan 2023: 67Feb 2023: 93Mar 2023: 79Apr 2023: 103May 2023: 59Jun 2023: 54Jul 2023: 75Aug 2023: 66Sep 2023: 36Oct 2023: 81Nov 2023: 51Dec 2023: 412024Jan 2024: 88Feb 2024: 73Mar 2024: 67Apr 2024: 73May 2024: 88Jun 2024: 86Jul 2024: 81Aug 2024: 113Sep 2024: 60Oct 2024: 86Nov 2024: 33Dec 2024: 252025Jan 2025: 51Feb 2025: 54Mar 2025: 87Apr 2025: 37May 2025: 33Jun 2025: 105Jul 2025: 101Aug 2025: 110Sep 2025: 73Oct 2025: 47Nov 2025: 50Dec 2025: 562026Jan 2026: 119Feb 2026: 59Mar 2026: 58Apr 2026: 104May 2026: 38Jun 2026: 103Jul 2026: 68Aug 2026: 23

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

05031,0062019: 9520192021: 1,00620212022: 80520222023: 80520232024: 87320242025: 80420252026: 5722026

Event type and report source

Event type, as classified on the report

Death0%0
Injury99.9%4,955
Malfunction0.1%5
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%4,960
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate2,20144.4%62.8%
Loss of osseointegration1,42028.6%22.4%
Osseointegration problem1,25225.2%7.7%
Fracturea broken bone601.2%1.6%
Damaged thread190.4%0%
Malposition of device70.1%0.1%
Difficult to insertthe device was hard to insert60.1%0.4%
Insufficient device problem information60.1%0.2%
Loosening of implant not related to bone-ingrowth20%0.1%
Separation failure20%0.1%
Improper or incorrect procedure or method10%0%
Patient device interaction problem10%0.3%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant4,95199.8%
Inflammationinflammation51510.4%
Osteolysis3066.2%
Pocket erosion2134.3%
Implant pain190.4%
Discomfortdiscomfort30.1%
Numbnessnumbness30.1%
Fistula20%
Osteopenia/ osteoporosis20%
Sinus perforation20%
Swelling/ edema20%
Deformity/ disfigurement10%
Hypoesthesia10%
Inadequate osseointegration10%
Painpain, site not specified10%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureANK C/X Impl B9.5/D4.5/L9.5Product code DZEAll MAUDE reports
Reports4,9603,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury99.9%99.2%36.2%
Classified as malfunction0.1%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about ANK C/X Impl B9.5/D4.5/L9.5 reports

How many FDA reports name ANK C/X Impl B9.5/D4.5/L9.5?

4,960 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 798 in the latest 12 months.

What kinds of events are reported?

injury (99.9%) and malfunction (0.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (44.4%), loss of osseointegration (28.6%), osseointegration problem (25.2%), fracture (1.2%) and damaged thread (0.4%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that ANK C/X Impl B9.5/D4.5/L9.5 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.